Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Luketic

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Hepatology (Baltimore, Md.)|June 30, 2001
Liver transplantation in patients with hepatitis B virus infection: outcome in Asian versus white patientsE K Teo, S H Han, N Terrault, et al.
Journal of Viral Hepatitis|May 5, 2017
Efficacy of 12 or 18 weeks of elbasvir plus grazoprevir with ribavirin in treatment-naïve, noncirrhotic HCV genotype 3-infected patientsE Gane, R Nahass, V Luketic, et al.
Clinical Transplantation|September 4, 2004
Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting listR A Fisher, D Maluf, A H Cotterell, et al.
Virginia Medical Quarterly : VMQ|January 1, 1990
Liver transplantation in VirginiaM L Shiffman, M P Posner, V Luketic, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 5, 2003
Non-resective ablation and liver transplantation in patients with cirrhosis and hepatocellular carcinoma (HCC): safety and efficacyD Maluf, R A Fisher, T Maroney, et al.
Alimentary Pharmacology & Therapeutics|July 6, 2011
Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experienceM M Tannous, J Cheng, K Muniyappa, et al.
Transplantation Proceedings|February 6, 2007
Multimodality therapy and liver transplantation in patients with cirrhosis and hepatocellular carcinoma: 6 years, single-center experienceD G Maluf, R T Stravitz, B Williams, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2011
PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosisJ S Bajaj, L R Thacker, J B Wade, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2012
Modified-orientation log to assess hepatic encephalopathyM Salam, S Matherly, I S Farooq, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2014
Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosisJ S Bajaj, D M Heuman, P B Hylemon, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Hepatology (Baltimore, Md.)|June 30, 2001
Liver transplantation in patients with hepatitis B virus infection: outcome in Asian versus white patientsE K Teo, S H Han, N Terrault, et al.
Journal of Viral Hepatitis|May 5, 2017
Efficacy of 12 or 18 weeks of elbasvir plus grazoprevir with ribavirin in treatment-naïve, noncirrhotic HCV genotype 3-infected patientsE Gane, R Nahass, V Luketic, et al.
Clinical Transplantation|September 4, 2004
Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting listR A Fisher, D Maluf, A H Cotterell, et al.
Virginia Medical Quarterly : VMQ|January 1, 1990
Liver transplantation in VirginiaM L Shiffman, M P Posner, V Luketic, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 5, 2003
Non-resective ablation and liver transplantation in patients with cirrhosis and hepatocellular carcinoma (HCC): safety and efficacyD Maluf, R A Fisher, T Maroney, et al.
Alimentary Pharmacology & Therapeutics|July 6, 2011
Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experienceM M Tannous, J Cheng, K Muniyappa, et al.
Transplantation Proceedings|February 6, 2007
Multimodality therapy and liver transplantation in patients with cirrhosis and hepatocellular carcinoma: 6 years, single-center experienceD G Maluf, R T Stravitz, B Williams, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2011
PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosisJ S Bajaj, L R Thacker, J B Wade, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2012
Modified-orientation log to assess hepatic encephalopathyM Salam, S Matherly, I S Farooq, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2014
Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosisJ S Bajaj, D M Heuman, P B Hylemon, et al.
Pageof 1